查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1842073

美国家庭输液治疗市场：市场规模、份额、趋势分析（按类型和应用）、细分市场预测（2025-2033 年）

U.S. Home Infusion Therapy Market Size, Share & Trends Analysis Report By Type, By Application, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

美国家庭输液治疗市场概览

据估计，2024 年美国家庭输液治疗市值为 204.2 亿美元，预计到 2033 年将达到 399.6 亿美元，2025 年至 2033 年的复合年增长率为 7.78%。

老年人口不断增长，且老年人容易患上严重的健康问题，这是推动市场成长的主要因素。

此外，癌症、糖尿病、慢性疼痛和胃肠道疾病等疾病的日益普遍预计将进一步推动美国市场的成长。居家输液疗法为患者带来许多好处，包括成本效益高、改善健康状况、更便捷以及安全标准更高。

老龄化是感染疾病及其併发症的主要风险因素之一。因此，美国人口的快速老化预计将推动市场成长。例如，根据美国国家人口问题研究所的数据，预计65岁及以上人口将从2022年的5,800万增加到2050年的8,200万人。越来越多的患者选择居家治疗也是推动市场成长的因素之一。居家医疗保健能够帮助患者进行日常活动，并提供更方便的专业医疗服务。与住院治疗相比，居家输液治疗无需住院，因此更具成本效益，减轻了患者的负担。此外，居家输液治疗还能降低病患在家中发生医院感染的风险，进而确保更高的安全性。这些因素共同推动了居家治疗的需求，并促进了市场成长。

美国癌症、糖尿病和其他慢性疾病的高发生率进一步推动了市场成长。根据美国癌症协会预测，2022年美国将新增近190万例癌症病例，并有609,360例癌症相关死亡病例。糖尿病在美国的盛行率也相当高，这主要归因于不良的生活方式和压力巨大的工作环境。此外，心血管疾病和慢性呼吸系统疾病的盛行率在美国也持续快速上升。预计在预测期内，老年人口的增长和外科手术量的增加等因素也将推动美国对静脉输液帮浦的需求。

此外，各国政府预计将推出更严格的法规并采纳新的标准，以提供更安全、更有效率的医疗服务。这项进展将透过提升国家医疗服务标准（包括输液治疗实践标准、输液护理政策和流程）以及改善个别医护人员的政策来实现。此外，新产品的上市和FDA的核准也显着促进了市场成长。例如，2024年4月，百特公司（Baxter）的Novum IQ大容量输液帮浦和Dose IQ安全软体获得了美国FDA的批准。这项进步将增强互联智慧输液治疗，进而提高病患安全性和医疗效率。

目录

第一章 分析方法和范围

第二章执行摘要

第三章美国家庭输液治疗市场：驱动因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 美国家庭输液治疗市场：分析工具
    • 产业分析：波特五力分析
    • PESTEL分析

第四章：美国家庭输液治疗市场：按类型分類的估算与趋势分析

  • 细分仪表板
  • 美国家庭输液治疗市场：按类型分類的差异分析
  • 美国家庭输液治疗市场规模及趋势分析（按类型划分）（2021-2033 年）
  • 产品
    • 点滴帮浦
    • 静脉输液装置
    • 静脉套管
    • 无针头连接器
  • 服务

第五章美国家庭输液治疗市场：按应用分類的估算与趋势分析

  • 细分仪表板
  • 美国家庭输液治疗市场：按应用分類的差异分析
  • 美国家庭输液治疗市场规模及应用趋势分析（2021-2033）
  • 抗感染疾病
  • 内分泌学
    • 糖尿病
    • 其他的
  • 水疗法
    • 运动员
    • 其他的
  • 化疗
  • 经肠营养
  • 肠外营养
  • 特种製药
  • 其他的

第六章 竞争情势

  • 公司/竞争对手分类
  • 策略规划
  • 企业市场分析（2024）
  • 公司简介/上市公司
    • B. Braun Melsungen
    • Baxter International
    • Caesarea Medical Electronics Ltd.
    • CareFusion
    • Fresenius Kabi
    • ICU Medical
    • JMS CO., LTD.
    • Smiths Medical, Inc.
    • Terumo Corporation
    • Coram LLC
    • Option Care Enterprises, Inc.
    • BioScrip, Inc.
    • BriovaRx Infusion Services
    • Paragon Healthcare
Product Code: GVR-3-68038-956-2

U.S. Home Infusion Therapy Market Summary

The U.S. home infusion therapy market size was estimated at USD 20.42 billion in 2024 and is expected to reach USD 39.96 billion by 2033, growing at a CAGR of 7.78% from 2025 to 2033. The increasing elderly population susceptible to severe health conditions is a significant factor driving market growth.

In addition, the rising prevalence of disorders such as cancer, diabetes, chronic pain, and gastrointestinal diseases is anticipated to further stimulate growth in the U.S. market. Home infusion therapy provides various advantages for patients, including cost-effectiveness, improved health outcomes, enhanced convenience, and elevated safety standards.

Aging is one of the leading risk factors for developing infections and associated complications. Thus, the rapidly aging U.S. population is anticipated to drive market growth. For instance, according to the Population Reference Bureau, the number of people aged 65 and older is projected to increase from 58 million in 2022 to 82 million by 2050. Increasing patients' preference for home therapy is also driving the market growth. Home healthcare supports the daily life activities of patients and provides better access to skilled medical care. As compared to hospital treatment, home infusion therapy is cost-effective since it eliminates hospital stays and ultimately saves the patient's money. Home infusion therapy also allows the patient to maintain higher safety due to less risk of hospital-acquired infections at home. This augments the demand for home treatment, thereby driving the market growth.

This country's high prevalence of cancer, diabetes, and other chronic diseases propels market growth further. According to the American Cancer Society, nearly 1.9 million new cancer cases were expected to be diagnosed with 609,360 cancer deaths in 2022. The prevalence of diabetes in the U.S is also quite significant, which can be attributed to negative lifestyle choices and a stressful work environment. Moreover, there has been a constant surge in the prevalence of cardiovascular and chronic respiratory diseases in the country. In addition, factors such as a growing geriatric population and increasing volume of surgical procedures are expected to propel the country's demand for intravenous infusion pumps in the forecast period.

Moreover, the government is expected to introduce stricter regulations and adopt new standards for safer & efficient practices. This progress is being achieved by improving national standards of care via the Infusion Therapy Standards of Practice and the Policies and Procedures for Infusion Nursing, along with upgrading policies of individual care providers. Moreover, new product launches and FDA approvals significantly contribute to market growth. For instance, in April 2024, Baxter received U.S. FDA clearance for its Novum IQ large volume infusion pump and Dose IQ safety software. This advancement enhances connected and intelligent infusion therapy, improving patient safety and care efficiency.

U.S. Home Infusion Therapy Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. home infusion therapy market report based on Type, and application.

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Product
    • Infusion PumpsIntravenous Sets
    • Elastomeric
    • Electromechanical
    • Gravity
    • Others
    • Intravenous Sets
    • IV Cannulas
    • Needleless Connectors
  • Services
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Anti-infective
  • Endocrinology
    • Diabetes
    • Others
  • Hydration Therapy
    • Athletes
    • Others
  • Chemotherapy
  • Enteral Nutrition
  • Parenteral Nutrition
  • Specialty Pharmaceuticals
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. Application Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. U.S. Home Infusion Therapy Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of chronic diseases and growing geriatric population
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Growing incidence of hospital-acquired infections
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Presence of complicated reimbursement framework and reimbursement cuts
  • 3.3. U.S. Home Infusion Therapy Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
      • 3.3.2.4. Environmental Landscape
      • 3.3.2.5. Legal Landscape
      • 3.3.2.6. Social Landscape

Chapter 4. U.S. Home Infusion Therapy Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Home Infusion Therapy Market Type Movement Analysis
  • 4.3. U.S. Home Infusion Therapy Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
  • 4.4. Product
    • 4.4.1. Market estimates and forecasts 2021 to 2033, (USD Million)
    • 4.4.2. Infusion pumps
      • 4.4.2.1. Market estimates and forecasts 2021 to 2033, (USD Million)
      • 4.4.2.2. Elastomeric
        • 4.4.2.2.1. Market estimates and forecasts 2021 to 2033, (USD Million)
      • 4.4.2.3. Electromechanical
        • 4.4.2.3.1. Market estimates and forecasts 2021 to 2033, (USD Million)
      • 4.4.2.4. Gravity
        • 4.4.2.4.1. Market estimates and forecasts 2021 to 2033, (USD Million)
      • 4.4.2.5. Others
        • 4.4.2.5.1. Market estimates and forecasts 2021 to 2033, (USD Million)
    • 4.4.3. Intravenous Sets
      • 4.4.3.1. Market estimates and forecasts 2021 to 2033, (USD Million)
    • 4.4.4. IV Cannulas
      • 4.4.4.1. Market estimates and forecasts 2021 to 2033, (USD Million)
    • 4.4.5. Needleless Connectors
      • 4.4.5.1. Market estimates and forecasts 2021 to 2033, (USD Million)
  • 4.5. Services
    • 4.5.1. Market estimates and forecasts 2021 to 2033, (USD Million)

Chapter 5. U.S. Home Infusion Therapy Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Home Infusion Therapy Market Application Movement Analysis
  • 5.3. U.S. Home Infusion Therapy Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. Anti-Infective
    • 5.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Endocrinology
    • 5.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.5.2. Diabetes
      • 5.5.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.5.3. Others
      • 5.5.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6. Hydration Therapy
    • 5.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.6.2. Athletes
      • 5.6.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.6.3. Others
      • 5.6.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.7. Chemotherapy
    • 5.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.8. Enteral Nutrition
    • 5.8.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.9. Parenteral Nutrition
    • 5.9.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.10. Specialty Pharmaceuticals
    • 5.10.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.11. Others
    • 5.11.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Company/Competition Categorization
  • 6.2. Strategy Mapping
  • 6.3. Company Market Position Analysis, 2024
  • 6.4. Company Profiles/Listing
    • 6.4.1. B. Braun Melsungen
      • 6.4.1.1. Company overview
      • 6.4.1.2. Financial performance
      • 6.4.1.3. Product benchmarking
      • 6.4.1.4. Strategic initiatives
    • 6.4.2. Baxter International
      • 6.4.2.1. Company overview
      • 6.4.2.2. Financial performance
      • 6.4.2.3. Product benchmarking
      • 6.4.2.4. Strategic initiatives
    • 6.4.3. Caesarea Medical Electronics Ltd.
      • 6.4.3.1. Company overview
      • 6.4.3.2. Financial performance
      • 6.4.3.3. Product benchmarking
      • 6.4.3.4. Strategic initiatives
    • 6.4.4. CareFusion
      • 6.4.4.1. Company overview
      • 6.4.4.2. Financial performance
      • 6.4.4.3. Product benchmarking
      • 6.4.4.4. Strategic initiatives
    • 6.4.5. Fresenius Kabi
      • 6.4.5.1. Company overview
      • 6.4.5.2. Financial performance
      • 6.4.5.3. Product benchmarking
      • 6.4.5.4. Strategic initiatives
    • 6.4.6. ICU Medical
      • 6.4.6.1. Company overview
      • 6.4.6.2. Financial performance
      • 6.4.6.3. Product benchmarking
      • 6.4.6.4. Strategic initiatives
    • 6.4.7. JMS CO., LTD.
      • 6.4.7.1. Company overview
      • 6.4.7.2. Financial performance
      • 6.4.7.3. Product benchmarking
      • 6.4.7.4. Strategic initiatives
    • 6.4.8. Smiths Medical, Inc.
      • 6.4.8.1. Company overview
      • 6.4.8.2. Financial performance
      • 6.4.8.3. Product benchmarking
      • 6.4.8.4. Strategic initiatives
    • 6.4.9. Terumo Corporation
      • 6.4.9.1. Company overview
      • 6.4.9.2. Financial performance
      • 6.4.9.3. Product benchmarking
      • 6.4.9.4. Strategic initiatives
    • 6.4.10. Coram LLC
      • 6.4.10.1. Company overview
      • 6.4.10.2. Financial performance
      • 6.4.10.3. Product benchmarking
      • 6.4.10.4. Strategic initiatives
    • 6.4.11. Option Care Enterprises, Inc.
      • 6.4.11.1. Company overview
      • 6.4.11.2. Financial performance
      • 6.4.11.3. Product benchmarking
      • 6.4.11.4. Strategic initiatives
    • 6.4.12. BioScrip, Inc.
      • 6.4.12.1. Company overview
      • 6.4.12.2. Financial performance
      • 6.4.12.3. Product benchmarking
      • 6.4.12.4. Strategic initiatives
    • 6.4.13. BriovaRx Infusion Services
      • 6.4.13.1. Company overview
      • 6.4.13.2. Financial performance
      • 6.4.13.3. Product benchmarking
      • 6.4.13.4. Strategic initiatives
    • 6.4.14. Paragon Healthcare
      • 6.4.14.1. Company overview
      • 6.4.14.2. Financial performance
      • 6.4.14.3. Product benchmarking
      • 6.4.14.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. home infusion therapy market, by product, 2021 - 2033 (USD Million)
  • Table 3 U.S. home infusion therapy market, by application, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 U.S. home infusion therapy market: Market outlook
  • Fig. 5 U.S. home infusion therapy market: Segment outlook
  • Fig. 6 U.S. home infusion therapy market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 U.S. home infusion therapy market driver impact
  • Fig. 9 U.S. home infusion therapy market restraint impact
  • Fig.10 U.S. home infusion therapy market: Type outlook and key takeaways
  • Fig.11 U.S. home infusion therapy market: Type movement analysis
  • Fig. 12 Infusion pumps market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 13 Elastomeric market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Electromechanical market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Gravity market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Intravenous sets market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 IV cannulas market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Needleless connectors market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 U.S. home infusion therapy market: Application outlook and key takeaways
  • Fig. 21 U.S. home infusion therapy market: Application movement analysis
  • Fig. 22 Anti-infective market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 23 Endocrinology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Diabetes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Hydration therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Athletes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Others market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 29 Chemotherapy market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 30 Enteral nutrition market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 31 Parenteral nutrition market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 32 Specialty pharmaceuticals market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 33 Others market estimates and forecast, 2021 - 2033 (USD Million)